Journal profile · Statistics & Probability
Journal of Biopharmaceutical Statistics
ISSN 1054-3406 · eISSN 1520-5711 · Taylor and Francis Ltd. · UNITED STATES · Bimonthly · Founded 1991
Journal of Biopharmaceutical Statistics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.41; JCR Q2 (journal website); subscription journal; APC charged, amount not published; median 297 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 93 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Biopharmaceutical Statistics is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Statistical Methods in Clinical Trials, Optimal Experimental Design Methods and Statistical Methods and Bayesian Inference, together about 52.2% of its articles. Its main subfields are Statistics and Probability. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of Biopharmaceutical Statistics , a rapid publication journal, discusses quality applications of statistics in biopharmaceutical research and development. Now publishing six times per year, it includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscripts, review articles, selected/invited conference papers, short articles, and letters to the editor. Addressing timely and provocative topics important to the biostatistical profession, the journal covers: Drug, device, and biological research and development Drug screening and drug design Assessment of pharmacological activity Pharmaceutical formulation and scale-up Preclinical safety assessment Bioavailability, bioequivalence, and pharmacokinetics Phase, I, II, and III clinical development including complex innovative designs Premarket approval assessment of clinical safety Postmarketing surveillance Big data and artificial intelligence and applications Peer Review Policy All submitted manuscripts are subject to initial appraisal by the Editors. If found suitable for further consideration, papers are subject to peer review by two independent, anonymous expert referees, each delivering at least one report under the guidance of a team of expert Associate Editors. All peer-review is single anonymous and submissions can be made online via the Submission Portal. Publishing Ethics Statement The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of the Committee of Publication Ethics (COPE) and utilizes Similarity Check for all Journals. More information on our ethical standards and policies can be found here: http://authorservices.taylorandfrancis.com/ethics-for-authors/. The Journal has an appeals and complaints policy which can be viewed here: https://authorservices.taylorandfrancis.com/peer-review-appeals-and-complaints-from-authors/ Author Benefits Editorial Board Author Services My Authored Works
From the journal's Aims & Scope
Research area (LetPub): Statistics & Probability
Editorial board by country: none in mainland China; most named United States 4 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Statistical Methods in Clinical TrialsMathematics30.1%
- Optimal Experimental Design MethodsDecision Sciences12.7%
- Statistical Methods and Bayesian InferenceMathematics9.4%
- Statistical Methods and InferenceMathematics7.9%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance7.2%
- Advanced Causal Inference TechniquesMathematics7.2%
- Meta-analysis and systematic reviewsDecision Sciences2.8%
- Computational Drug Discovery MethodsComputer Science2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Statistics & Probability | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Statistics & Probability | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
| Minor | Statistics & Probability | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbasezbMATHPublisher website
Other: ProQuest, OCLC, Adis International Ltd. Reactions Weekly (Online), EBSCOhost (various), E-psyche, Genamics JournalSeek, OCLC ArticleFirst Electronic Collections Online, ProQuest (various), Statistical Theory and Method Abstracts (CD-ROM)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.41LetPub ·
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.4Publisher website ·
- CiteScore 2026-06
- 2.7LetPub ·
- CiteScore (publisher) 2025
- 2.7Publisher website ·
- SJR 2026-06
- 0.68LetPub ·
- SJR (publisher) 2025
- 0.68Publisher website ·
- SNIP 2026-06
- 0.87LetPub ·
- SNIP (publisher) 2025
- 0.87Publisher website ·
- h-index
- 43LetPub ·
- h-index
- 73OpenAlex ·
- i10-index
- 863OpenAlex ·
- 2-year mean citedness
- 1OpenAlex ·
- Self-citation rate
- 15.4%LetPub ·
- Share of gold OA articles
- 4.09%LetPub ·
Volume
- Articles per year
- 86LetPub ·
- Downloads per year (publisher)
- 115,000Publisher website ·
Articles by year OpenAlex count · 2,609 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 82 | 19 | 16 |
| 2025 | 93 | 17 | 80 |
| 2024 | 102 | 22 | 182 |
| 2023 | 98 | 33 | 402 |
| 2022 | 84 | 22 | 449 |
| 2021 | 57 | 20 | 432 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
297 daysMedian, submission to acceptance · P25–P75 224 days – 425 days
- Acceptance to online
- median 23 days (97 articles)
- Submission to online
- median 330 days
- Sample
- 97 articles with submission and acceptance dates (200 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 31%Publisher website ·
- Submission to first decision
- 61 daysPublisher website ·
- First decision after review
- 86 daysPublisher website ·
- Acceptance to publication
- 23 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted6
- full-length manuscriptsit includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscriptsLength not stated
- letters to the editorreview articles, selected/invited conference papers, short articles, and letters to the editorLength not stated
- review articlesreview articles, selected/invited conference papers, short articles, and letters to the editorLength not stated
- selected/invited conference papersreview articles, selected/invited conference papers, short articles, and letters to the editorLength not stated
- short articlesreview articles, selected/invited conference papers, short articles, and letters to the editorLength not stated
- short manuscriptsit includes expositions of statistical methodology with immediate applicability to biopharmaceutical research in the form of full-length and short manuscriptsLength not stated
Policy excerpts from the journal's websitePublication ethics, Open access, Peer review
- Publication ethics
Publishing ethics: COPE member, Similarity Check used, appeals and complaints policy available. Model summary
The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of the Committee of Publication Ethics (COPE) and utilizes Similarity Check for all Journals.
Source ↗Publisher website ·- Open access Open access
Open access: hybrid journal under Taylor & Francis Open Select; optional OA publishing with APC; no APC if not choosing OA. Model summary
Journal of Biopharmaceutical Statistics is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the dis…
Source ↗Publisher website ·- Peer review
Peer review policy: initial editor appraisal; peer review by two independent anonymous referees; single anonymous review; online submission via portal. Model summary
All submitted manuscripts are subject to initial appraisal by the Editors. If found suitable for further consideration, papers are subject to peer review by two independent, anonymous expert referees, each delivering at least one report under the guidance of a team of expert Associate Editors. All peer-review is single anonymous and submissions can be made online via the Submission Portal.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1991
- ISSN
- 1054-3406
- Electronic ISSN
- 1520-5711
- Latest issue on the website
- Volume 36, Issue 5 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of Biopharmaceutical Statistics
What CAS zone is Journal of Biopharmaceutical Statistics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Biopharmaceutical Statistics is in Zone 4 of Medicine, and in Zone 3 of the minor category Statistics & Probability / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Biopharmaceutical Statistics?
The latest impact factor listed by LetPub is 1.41; CiteScore 2.7, h-index 73.
How long does peer review take at Journal of Biopharmaceutical Statistics?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 297 days (interquartile range 224–425 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 31%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Journal of Biopharmaceutical Statistics in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Where are the editorial board members of Journal of Biopharmaceutical Statistics based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Biopharmaceutical Statistics?
According to LetPub and DOAJ records, Journal of Biopharmaceutical Statistics is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and zbMATH; that list has not been checked against each database.
Is Journal of Biopharmaceutical Statistics open access, and what is the APC?
Journal of Biopharmaceutical Statistics is a subscription journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .